Methyl 3-(4-formyl-2-nitrophenoxy)benzoate

Catalog No. :
ACLASD237
CAS No. :
439095-08-6
Molecular Formula :
C15H11NO6
Molecular Weight :
301.25

IUPAC Name:methyl 3-(4-formyl-2-nitrophenoxy)benzoate

Methyl 3-(4-formyl-2-nitrophenoxy)benzoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg97%$124.00Login to see priceInquiryInquiry
250mg97%$178.00Login to see priceInquiryInquiry
1g97%$253.00Login to see priceInquiryInquiry
5g97%$654.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 3-(4-formyl-2-nitrophenoxy)benzoate
IUPAC Namemethyl 3-(4-formyl-2-nitrophenoxy)benzoate
MDL No.MFCD03425737
Molecular FormulaC15H11NO6
Molecular Weight301.25
SMILESO=C(C1=CC=CC(OC2=CC=C(C=O)C=C2[N+]([O-])=O)=C1)OC
InChI KeyDRKPDPYIKLBLRR-UHFFFAOYSA-N
SynonymMETHYL 3-(4-FORMYL-2-NITROPHENOXY)BENZENECARBOXYLATE;Benzoic acid, 3-(4-formyl-2-nitrophenoxy)-, methyl ester;Methyl 3-(4-formyl-2-nitrophenoxy)benzoate
CAS No.439095-08-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLASD237 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFQVD563 route compound structure diagram
    ACFQVD56319438-10-9 In Stock
  2. Plus
  3. ACNPSI759 route compound structure diagram
    ACNPSI75916588-34-4 In Stock
  4. Then
  5. ACLASD237 route product structure diagram
    ACLASD237439095-08-6
Inquiry

2. ACLASD237 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFQVD563 route compound structure diagram
    ACFQVD56319438-10-9 In Stock
  2. Plus
  3. ACYKUX528 route compound structure diagram
    ACYKUX52842564-51-2 In Stock
  4. Then
  5. ACLASD237 route product structure diagram
    ACLASD237439095-08-6
Inquiry

Comments (0)